Skip to main content
Displaying 13 - 24 of 51
Display:
12
24
48
Liver Tumours
AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection (Complete Sess...
Webcasts
View
Liver Tumours
Panel discussion: Management of patients with HCC in the evolving landscape
Webcasts
View
Liver Tumours
How we treat patients with unresectable HCC: expert views on choosing the optimal treatment
Webcasts
View
Liver Tumours
Q&A
Webcasts
View
Liver Tumours
Welcome and introductions
Webcasts
View
Liver Tumours
Roche: Unveiling the key factors: critical aspects in HCC treatment today (Complete Session)
Webcasts
View
Liver Tumours
Introduction
Webcasts
View
Liver Tumours
General Overview on liver imaging, when do we need MRI? Benefits of liver-specific agents
Webcasts
View
Liver Tumours
Imaging of HCC, results of the SORAMIC trial and treatment stratification in HCC
Webcasts
View
Liver Tumours
Q&A
Webcasts
View
Liver Tumours
Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver ...
Webcasts
View
Liver Tumours
Clinical impact of non-arterial enhancing lesions in patients at risk of HCC - therapy and follow-up
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Page
4
Page
5
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy